SCHEMBL21102740

SCHEMBL21102740

CN(CC[C@H](Oc1ccccc1Br)c1cccs1)C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA2D1 P54289 6/20 0.42
▸ GBA1 P04062 1/20 0.41
▸ SLC6A2 P23975 10/20 0.39
▸ SLC6A4 P31645 10/20 0.39
▸ SLC6A3 Q01959 10/20 0.39
▸ HTR1A P08908 2/20 0.39
▸ MLNR O43193 1/20 0.39
▸ CACNA1F O60840 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ ADRB1 P08588 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ KCNE1 P15382 1/20 0.39
▸ ADRA2B P18089 1/20 0.39
▸ ADRA2C P18825 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21102625 1.00 CACNA2D1 (0.42) CACNA2D1GBA1SLC6A2SLC6A4SLC6A3
SCHEMBL21102742 0.87 GBA1 (0.42) CACNA2D1GBA1SLC6A2SLC6A4SLC6A3
SCHEMBL21051931 0.86 CACNA2D1 (0.45) CACNA2D1SLC6A2SLC6A4SLC6A3HTR1A
Lithium Ion SCHEMBL21061319 0.85 CACNA2D1 (0.40) CACNA2D1GBA1SLC6A2SLC6A4SLC6A3
SCHEMBL21102738 0.84 SLC6A9 (0.46) SLC6A4
SCHEMBL21102739 0.84 SLC6A9 (0.46) SLC6A4
SCHEMBL21102741 0.84 SLC6A9 (0.46) SLC6A4
SCHEMBL20309012 0.80 GBA1 (0.45) GBA1SLC6A4HTR1AHTR2CKMT2A
SCHEMBL29457634 0.80 GBA1 (0.45) GBA1SLC6A4HTR1AHTR2CKMT2A
SCHEMBL29967173 0.80 GBA1 (0.45) GBA1SLC6A4HTR1AHTR2CKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019115008-A1 DIALKYLAMINOARYLPIPERIDINYL-O-PHENOXY AND O-BENZYLOXYPROPYLAMINO DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2019-06-20 — — WO disclosed
Send feedback